Direxion Daily S&P Biotech Bull 3X ETF
LABU
35 hedge funds and large institutions have $23.3M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 8 closing their positions.
12% more call options, than puts
Call options by funds: $46.3M | Put options by funds: $41.5M
2.27% less ownership
Funds ownership: 6.47% → 4.19% (-2.3%)
8% less funds holding
Funds holding: 38 → 35 (-3)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
55% less capital invested
Capital invested by funds: $51.9M → $23.3M (-$28.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$6.23M |
| 2 |
Squarepoint
New York
|
+$2.1M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$947K |
| 4 |
EFG
Ethos Financial Group
King Of Prussia,
Pennsylvania
|
+$578K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$437K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$10.3M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.19M |
| 3 |
VF
Virtu Financial
New York
|
-$3.04M |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$2.94M |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$1.49M |
LABU Hedge Fund Activity: Q1 2025 in Review
35 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2025, worth a combined $23.3M — down 55% from $51.9M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LABU and 5 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Jane Street, opening a new position worth an estimated $6.23M. The largest seller was Citadel Advisors, exiting entirely with an estimated $10.3M sold.
- 35 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2025, down from 38 in Q4 2024.
- Funds reported $23.3M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2025, down 55% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2025 and 8 closed out, a net change of -3 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2025 was Jane Street, an estimated $6.23M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2025 was Citadel Advisors, an estimated $10.3M sold.
Based on aggregated 13F filings for Q1 2025.